pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Endocrinology & Metabolism · news · pharmadog
← back to Endocrinology & Metabolism
News · Endocrinology & Metabolism
432
stories
27d
Health insurance premiums jump 9%, and more Americans don’t have access to coverage
stat
28d
STAT+: Another diabetes association leader is out while review continues
stat
29d
The 6 biggest crossover rounds in biopharma history
biospace
29d
Hologic snaps up Reveal Genomics to boost genomic diagnostic reach
fiercebiotech
Oct 20, 26
AstraZeneca taps Oracle to help improve recruitment for clinical trials
fiercebiotech
Oct 19, 26
Trump orders creation of NIH division, task force on women’s health
stat
Oct 19, 26
Merck KGaA makes noise in hematology with $1.1B Silence buy
biospace
Oct 19, 26
Merck KGaA bets on RNAi with $1.3B Silence buyout
biopharma dive
Oct 19, 26
Opinion: My mother killed herself. I wish assisted suicide had been an option
stat
Oct 19, 26
Disc spins past FDA rejection with ‘overwhelmingly positive’ phase 3 data for rare disease drug
fiercebiotech
Oct 19, 26
AbbVie’s next-gen Crohn’s disease combo beats Skyrizi in phase 2 trial
fiercebiotech
Oct 19, 26
From cells to organoids: Cytokines that shape 3D culture
biospace
Oct 16, 26
Iambic CEO on taking an AI drug company public
biopharma dive
Oct 16, 26
Hospitals’ next lucrative bet — longevity clinics
stat
Oct 16, 26
Labcorp, Thrive Global launch latest Thrive 5 health test
fiercebiotech
Oct 15, 26
Trump administration advances plan for peptide drugs favored by RFK Jr.
stat
Oct 15, 26
STAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer
stat
Oct 15, 26
AstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitro
biospace
Oct 15, 26
OMass Therapeutics collects $310M to chase Neurocrine, Vertex in genetic adrenal disorder
endpoints
Oct 15, 26
AstraZeneca inks $1.5B insitro deal for AI-enabled target discovery of liver, heart disease drugs
fiercebiotech
Oct 14, 26
Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs
biospace
Oct 14, 26
Zealand inks up to $1.3B deal for AI-designed obesity treatments
endpoints
Oct 14, 26
Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
stat
Oct 14, 26
Zealand inks $1.2B Generate pact to add multispecific proteins to obesity pipeline
fiercebiotech
Oct 14, 26
Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
fda medwatch
Oct 13, 26
Another Paragon spinout goes public through reverse merger
biopharma dive
Oct 13, 26
Roche extends China deal streak with $1B pact for RNAi obesity drug
biopharma dive
Oct 13, 26
Beam suggests it can correct mutation; Pfizer to collaborate with Enodia
endpoints
Oct 13, 26
Roche expands obesity R&D footprint with Rona deal worth $1B+
biospace
Oct 13, 26
Roche inks $1.2B deal with China's Rona to enter emerging ALK7 obesity race
fiercebiotech
← prev
page 3 of 15
next →